Clarus Therapeutics Holdings Inc. Gains 28.23%

Tue, May 03, 2022 at 05:35 PM
Clarus Therapeutics Holdings Inc. Gains 28.23%

Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ) soared at $0.71, a gain of 28.2%. On Mon, May 02, 2022, CRXT:NASDAQ touched a New 2-Week Low of $0.55. The stock got featured on our News Catalysts scanner on Thu, Apr 28, 2022 at 10:15 AM in the 'PATENT' category. From Tue, Apr 19, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days

The stock spiked on Wed, Apr 20, 2022 at $3.94 with a volume of 236M+.

About Clarus Therapeutics Holdings Inc. (CRXT:NASDAQ)

Clarus Therapeutics Holdings Inc is a pharmaceutical company with expertise in developing androgen and metabolic therapies for men and women, including potential therapies for orphan indications.

Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.